[ET Net News Agency, 14 February 2024] HANSOH PHARMA (03692) rose 5.2% to HK$12.84,
breaking above the 20-D SMA of HK$12.279.
It hits an intra-day high of HK$12.84, and an intra-day low of HK$11.86. The total
shares traded was 1.96 million, with a value of HK$24.44m. The active buy/sell ratio is
65:35, with net buying turnover of HK$6.9m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$1.11m, with volume weighted average price of HK$12.48.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$2.05m,
with volume weighted average price of HK$12.494.
The Hang Seng Index now rose 134 points, or 0.9% to 15,880.
Basic Information
=================
---------------------------------
Nominal 12.840 % Chg +5.25%
High 12.840 Low 11.860
Shares Tr 1.96m Turnover 24.44m
10-D SMA 12.202 %H.V 60.066
20-D SMA 12.279 VWAP 12.473
50-D SMA 13.708 RSI14 50.980
---------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 65:35, with net buying
turnover of HK$6.9m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 12.84 +5.25
ALI HEALTH (00241) 3.15 +0.32
CSPC PHARMA (01093) 5.96 +1.71
SINOPHARM (01099) 20.85 +0.72
SINO BIOPHARM (01177) 2.95 +1.37
WUXI APPTEC (02359) 39.45 -16.51
CHINARES PHARMA (03320) 4.89 -3.93
SCICLONE PHARMA (06600) 10.98 -1.44
JD HEALTH (06618) 28.10 +1.26
GOLDEN THROAT (06896) 3.46 -2.26
-----------------------------------------------
(ed)